Skip to main content

Monterey Bio Acquisition Corporation (MTRY)

Monterey Bio Acquisition will go public soon, but the exact IPO date is still unknown.
Stock Price: $10.00
Confirmed IPO price
Chart not available yet
Market Cap125.00M
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Out12.50M
EPS (ttm)n/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Openn/a
Previous Closen/a
Day's Rangen/a
52-Week Rangen/a
Betan/a
Analystsn/a
Price Targetn/a
Est. Earnings Daten/a

About MTRY

Monterey Bio Acquisition Corporation is a blank check company whose business purpose is to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. While we may pursue an initial business combination in any region or sector, we intend to focus our efforts on a biotech company that has demonstrated success and is primed to thrive in the rapidly evolving biotech industry for our initial business combination. It is our goa...

IndustryBlank Checks / SPAC
IPO DatePending
CEOSanjeev Satyal
CountryUnited States
Stock ExchangeNASDAQ
Ticker SymbolMTRY
Full Company Profile

News

Monterey Bio Acquisition IPO Registration Document (S-1)

Monterey Bio Acquisition Corporation has filed to go public with an IPO on the NASDAQ.

2 weeks ago - SEC